Evidence map›Paper›PMID 26108893›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2016

Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation.

Megan M Weivoda, Ming Ruan, Larry Pederson, Christine Hachfeld, Rachel A Davey, Jeffrey D Zajac, Jennifer J Westendorf, Sundeep Khosla, Merry Jo Oursler

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Trabecular bone remodeling in the aging mouse: A micro-multiphysics agent-basedFrontiers in bioengineering and biotechnology · 2023
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Megan M WeivodaDivision of Endocrinology, Metabolism, Nutrition, and Diabetes, Mayo Clinic, Rochester, MN, USA.
Ming RuanDivision of Endocrinology, Metabolism, Nutrition, and Diabetes, Mayo Clinic, Rochester, MN, USA.
Larry PedersonDivision of Endocrinology, Metabolism, Nutrition, and Diabetes, Mayo Clinic, Rochester, MN, USA.
Christine HachfeldDivision of Endocrinology, Metabolism, Nutrition, and Diabetes, Mayo Clinic, Rochester, MN, USA.
Rachel A DaveyDepartment of Medicine, Austin Health, University of Melbourne, Parkville, Victoria, Australia.
Jeffrey D ZajacDepartment of Medicine, Austin Health, University of Melbourne, Parkville, Victoria, Australia.
Jennifer J WestendorfDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Sundeep KhoslaDivision of Endocrinology, Metabolism, Nutrition, and Diabetes, Mayo Clinic, Rochester, MN, USA.
Merry Jo OurslerDivision of Endocrinology, Metabolism, Nutrition, and Diabetes, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USWinnMed · USAustin Health · AUUniversity of Melbourne · AU

Funding

SEX STEROIDS, GROWTH FACTORS, &BONE CELL FUNCTIONP01AG004875 · NIA · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 1985 to 2019
$30.8M
Musculoskeletal Research Training ProgramT32AR056950 · NIAMS · MAYO CLINIC ROCHESTER · PI Jennifer J Westendorf · 2009 to 2026
$7.0M
Osteoclast Regulation of Bone FormationR01AR067129 · NIAMS · MAYO CLINIC ROCHESTER · PI OURSLER, MERRY JO · 2015 to 2019
$3.0M
Canonical and Noncanonical Wnt Signaling in Osteoclast FunctionsR01AR065402 · NIAMS · MAYO CLINIC ROCHESTER · PI OURSLER, MERRY JO, WESTENDORF, JENNIFER J · 2015 to 2019
$2.4M
The Role of Podocalyxin in Osteoclast Activity and Bone MetabolismF32AR064679 · NIAMS · MAYO CLINIC ROCHESTER · PI WEIVODA, MEGAN M · 2013 to 2014
$84k
NIAMS NIH HHS F32 AR064679NIAMS NIH HHS R01 AR065402NIAMS NIH HHS R01 AR067129NIAMS NIH HHS T32 AR056950NIA NIH HHS P01 AG004875
6 · The paper itself

Abstract

Osteoblast-mediated bone formation is coupled to osteoclast-mediated bone resorption. These processes become uncoupled with age, leading to increased risk for debilitating fractures. Therefore, understanding how osteoblasts are recruited to sites of resorption is vital to treating age-related bone loss. Osteoclasts release and activate TGF-β from the bone matrix. Here we show that osteoclast-specific inhibition of TGF-β receptor signaling in mice results in osteopenia due to reduced osteoblast numbers with no significant impact on osteoclast numbers or activity. TGF-β induced osteoclast expression of Wnt1, a protein crucial to normal bone formation, and this response was blocked by impaired TGF-β receptor signaling. Osteoclasts in aged murine bones had lower TGF-β signaling and Wnt1 expression in vivo. Ex vivo stimulation of osteoclasts derived from young or old mouse bone marrow macrophages showed no difference in TGF-β-induced Wnt1 expression. However, young osteoclasts expressed reduced Wnt1 when cultured on aged mouse bone chips compared to young mouse bone chips, consistent with decreased skeletal TGF-β availability with age. Therefore, osteoclast responses to TGF-β are essential for coupling bone resorption to bone formation, and modulating this pathway may provide opportunities to treat age-related bone loss.

Indexed as

AnimalsBone ResorptionGene Expression RegulationMiceMice, TransgenicOsteoclastsOsteogenesisReceptors, Transforming Growth Factor betaWnt1 ProteinWnt Signaling PathwayReceptors, Transforming Growth Factor betaWnt1 ProteinWnt1 protein, mouseBONE REMODELINGCOUPLINGOSTEOCLASTTGF-βWNT1

Identifiers

PMID26108893
PMCPMC4758668
OpenAlexW1589662636

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.